nepafenac
Sign in to saveAlso known as AHR-9434, AL-6515, Nevanac®, AHR 9434, 2-amino-3-benzoylbenzeneacetamide, AL 6515, Amfenac amide, Nepafenacum
Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 activity.
Research
288 papers- Nepafenac.2006
- Nepafenac in cataract surgery.Clinical & experimental optometry · 2022
- Nepafenac.Australian prescriber · 2017
- Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.The Annals of pharmacotherapy · 2013
- Nepafenac: a unique nonsteroidal prodrug.International ophthalmology clinics · 2006
via PubMed
~7 min read
Encyclopedic overview
13 sectionsContents
- Medical uses
- Pharmacology
- Mechanism of action
- Adverse events
- Regulatory
- Nevanac
- Ilevro
- Commercialization
- Commercial risks
- Marketing
- Intellectual property
- References
- External links
Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 activity.
==Medical uses==
Excerpted from Wikipedia’s “nepafenac” article, available under the CC BY-SA 4.0 licence.